| 2D Structure | |
| CID | 446598 |
| IUPAC Name | (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide |
| InChI | InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1 |
| InChI Key | KDLRVYVGXIQJDK-AWPVFWJPSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C18H33ClN2O5S |
| Molecular Weight | 425.0 |
| synonyms | ['clindamycin', '18323-44-9', 'Chlolincocin', 'Clinimycin', 'Clindamicina', 'Clindamycine', '7-Chlorolincomycin', '7(S)-Chloro-7-deoxylincomycin', 'Clindamycinum', '7-Chloro-7-deoxylincomycin', '7-Deoxy-7(S)-chlorolincomycin', 'U-21251', 'U-21,251', '3U02EL437C', 'DTXSID2022836', '7-CDL', '(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide', 'L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-', 'L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, (2S-trans)-', 'L-threo-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, trans-alpha-', 'Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside', 'CHEBI:3745', 'Chlorlincocin', '(2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide', 'ClindaMed Oral Drops', 'RefChem:54845', 'clindamycini hydrochloridum', '7 Chloro 7 deoxylincomycin', 'Monohydrochloride, Clindamycin', 'Clindamycin in percent Dextrose', 'DTXCID102836', 'D10AF01', 'G01AA10', 'J01FF01', 'Clindamycin In 5 Percent Dextrose', '(2S,4R)-N-(2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide', 'Monohydrate Clindamycin Monohydrochloride', 'Monohydrochloride, Monohydrate Clindamycin', '242-209-1', 'Clindamax', 'Dalacine', 'Dalacin C', 'Sobelin', 'Cleocin', 'U 21251', 'Klimicin', 'ClindaDerm', 'L-threo-a-D-galacto-Octopyranoside, methyl7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-', 'Klindan 300', '(2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide', 'Clindamycine [French]', 'Clindamycine [INN-French]', 'Clindamycinum [INN-Latin]', 'Clindamicina [INN-Spanish]', 'C18H33ClN2O5S', '(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide', 'methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside', 'UNII-3U02EL437C', 'Clindamycin [USAN:INN:BAN]', 'SR-05000001477', 'HSDB 3037', 'Clindamycin Phosphate EP Impurity E', 'EINECS 242-209-1', 'Clindamycin (Standard)', 'CLINDAMYCIN [MI]', 'CLINDAMYCIN [INN]', 'Clindamycin (USAN/INN)', 'CLINDAMYCIN [HSDB]', 'CLINDAMYCIN [USAN]', 'Clindamycin & VRC3375', 'CLINDAMYCIN [VANDF]', 'SCHEMBL3154', 'CHEMBL1753', 'CLINDAMYCIN [MART.]', 'CLINDA & IL-12', 'CLINDAMYCIN [WHO-DD]', 'BIDD:GT0418', 'Clindamycin & Interleukin 12', 'orb1300761', 'CLINDAMYCIN [GREEN BOOK]', 'GTPL10607', 'HY-B1455R', 'HMS2089A05', 'HMS2089N16', 'HY-B1455', 'L-THREO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, (2S-TRANS)-', 'Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-.alpha.-D-galacto-octopyranoside', 'EBC-27053', 'MSK7803-100M', 'AKOS037515852', 'MSK7803-1000M', 'AC34039', 'CCG-268941', 'NCGC00263950-11', 'NCGC00263950-16', '(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide', 'CS-11147', 'L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-', 'Clindamycin Solution in Methanol, 100ug/mL', 'CS-0013163', 'NS00098633', 'Clindamycin Solution in Methanol, 1000ug/mL', 'C06914', 'D00277', 'G60910', 'AB01275425-01', 'AB01275425_02', 'EN300-19736038', 'SR-05000001477-1', 'CLINDAMYCIN PHOSPHATE IMPURITY E [EP IMPURITY]', 'L-threo-?-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-', 'methyl 7-chloro-6,7,8-trideoxy-6-({[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl}amino)-1-thio-L-threo-alpha-D-galacto-octopyranoside'] |
From Pubchem